Penumbra Inc. logo

Penumbra Inc. (PEN)

Market Open
21 Jul, 13:39
NYSE NYSE
$
317. 47
-0.54
-0.1698%
$
12.51B Market Cap
231.58 P/E Ratio
- Div Yield
4,627 Volume
2.03 Eps
$ 318.01
Previous Close
Add Transaction
Day Range
317 317.55
Year Range
221.26 362.41
Want to track PEN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Penumbra (PEN) Beats Q4 Earnings and Revenue Estimates

Penumbra (PEN) Beats Q4 Earnings and Revenue Estimates

Penumbra (PEN) came out with quarterly earnings of $0.97 per share, beating the Zacks Consensus Estimate of $0.91 per share. This compares to earnings of $0.76 per share a year ago.

Zacks | 1 year ago
Should You Add Penumbra Stock to Your Portfolio Right Now?

Should You Add Penumbra Stock to Your Portfolio Right Now?

PEN continues to attract investor interest with its strong portfolio expansion and global expansion efforts.

Zacks | 1 year ago
3 Reasons Why Growth Investors Shouldn't Overlook Penumbra (PEN)

3 Reasons Why Growth Investors Shouldn't Overlook Penumbra (PEN)

Penumbra (PEN) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Zacks | 1 year ago
Penumbra (PEN) Surges 6.3%: Is This an Indication of Further Gains?

Penumbra (PEN) Surges 6.3%: Is This an Indication of Further Gains?

Penumbra (PEN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Zacks | 1 year ago
Reasons to Add Penumbra Stock to Your Portfolio Now

Reasons to Add Penumbra Stock to Your Portfolio Now

PEN stays on investors' radars due to its strong Thrombectomy business and international growth plans.

Zacks | 1 year ago
Is Penumbra (PEN) a Solid Growth Stock? 3 Reasons to Think "Yes"

Is Penumbra (PEN) a Solid Growth Stock? 3 Reasons to Think "Yes"

Penumbra (PEN) could produce exceptional returns because of its solid growth attributes.

Zacks | 1 year ago
Here's Why Penumbra (PEN) is a Strong Growth Stock

Here's Why Penumbra (PEN) is a Strong Growth Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 1 year ago
4 Large Cap MedTech Stocks to Keep Winning Streaks Alive in 2025

4 Large Cap MedTech Stocks to Keep Winning Streaks Alive in 2025

Investing in large-cap MedTech stocks like MCK, PEN, CAH and PEN can be profitable for investors in 2025.

Zacks | 1 year ago
Here's Why Penumbra (PEN) is a Strong Momentum Stock

Here's Why Penumbra (PEN) is a Strong Momentum Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 1 year ago
Penumbra Is Poised For Growth As Blood Clot Awareness Rises: Analyst

Penumbra Is Poised For Growth As Blood Clot Awareness Rises: Analyst

Shares of Penumbra Inc PEN recovered slightly in early trading on Tuesday, after a week of correction.

Benzinga | 1 year ago
Penumbra (PEN) is an Incredible Growth Stock: 3 Reasons Why

Penumbra (PEN) is an Incredible Growth Stock: 3 Reasons Why

Penumbra (PEN) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Zacks | 1 year ago
Why Penumbra (PEN) is a Top Growth Stock for the Long-Term

Why Penumbra (PEN) is a Top Growth Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 1 year ago
Loading...
Load More